The largest database of trusted experimental protocols

Universal viral transport media system

Manufactured by BD

The BD Universal Viral Transport Media system is a collection and transport device designed to maintain the viability of a variety of viruses, including SARS-CoV-2. It provides a sterile, swab-based collection kit and a liquid medium to preserve viral samples during transport to a laboratory for testing.

Automatically generated - may contain errors

8 protocols using universal viral transport media system

1

Comparative RNA-seq analysis of viral infections

Check if the same lab product or an alternative is used in the 5 most similar protocols
We investigated a range of RNA-seq datasets in which primary cells or cell lines were infected with different pathogens including the three betacoronaviruses as well as the influenza virus H3N2, the bacterium Streptococcus pneumonia, Hepatitis C virus, Zika virus, Dengue virus, and Respiratory Syncytial Virus. All these datasets were downloaded from the National Center for Biotechnology Information's (NCBI) Sequence Read Archive (SRA) [19 (link)]. Infection of cell lines or primary cells with virus is a commonly used experimental system to investigate host dependency factors and host restriction factors [20 (link)].
An additional, clinical dataset was analyzed from nasopharyngeal swab specimens (SARS-CoV-2-A) from the New York-Presbyterian Hospital-Weill Cornell Medical Center [27 (link)]. We will refer to this dataset as SARS-CoV-2-A in the text. Briefly, nasopharyngeal swabs were collected using the BD Universal Viral Transport Media system (Becton, Dickinson and Company, Franklin Lakes, NJ) from symptomatic patients. Total Nucleic Acid (TNA) was extracted using automated nucleic acid extraction on the QIAsymphony and the DSP Virus/Pathogen Mini Kit (Qiagen). RNA isolation and library preparation is fully described in Butler, et al. [27 (link)].
+ Open protocol
+ Expand
2

SARS-CoV-2 Total RNA-seq Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were collected and processed through the Weill Cornell Medicine Institutional Review Board (IRB) Protocol 19-11021069. Dates of collected data for SARS-CoV-2 suspected patients was extracted from the electronic health records at NYP-CUIMC. We used data collected starting on March 10th, 2020 through April 20th, 2020. We applied this total RNA-seq platform to 732 clinical samples, including 669 confirmed or suspected COVID-19 cases at New York-Presbyterian Hospital-Weill Cornell Medical Center (NYPH-WCMC). Prior to analysis, duplicate samples, environmental samples, and seq control samples were removed. Only samples with over 2 million human genome aligned reads were included in the expression analysis (Figure S1B). Raw data are available at the database of Genotypes and Phenotypes dbGAP (accession #38851 and dbGAP: phs002258.v1.phs).
Patient specimens were collected with patients’ consent at New York-Presbyterian Hospital-Weill Cornell Medical Center (NYPH-WCMC) and then processed for qRT-PCR. Nasopharyngeal (NP) swab specimens were collected using the BD Universal Viral Transport Media system (Becton, Dickinson and Company, Franklin Lakes, NJ) from symptomatic patients. Sex was not a determining factor (nor recorded) since it was the first wave of the pandemic and we took all samples that came to the hospital.
+ Open protocol
+ Expand
3

Transcriptome Analysis of Pathogen-Infected Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
We investigated a range of RNA-seq datasets in which primary cells or cell lines were infected with different pathogens including the three betacoronaviruses as well as the influenza virus H3N2, the bacterium Streptococcus pneumonia, Hepatitis C virus, Zika virus, Dengue virus, and Respiratory Syncytial Virus. All these datasets were downloaded from NCBI’s Short Read Archive (SRA) [19 (link)]. Infection of cell lines or primary cells with virus is a commonly used experimental system to investigate host dependency factors and host restriction factors [20 ].
An additional, clinical dataset was analyzed from nasopharyngeal swab specimens (NPSS) from the New York-Presbyterian Hospital-Weill Cornell Medical Center [27 (link)]. We will refer to this dataset as SARS-CoV-2-A in the text. Briefly, nasopharyngeal swabs were collected using the BD Universal Viral Transport Media system (Becton, Dickinson and Company, Franklin Lakes, NJ) from symptomatic patients. Total Nucleic Acid (TNA) was extracted using automated nucleic acid extraction on the QIAsymphony and the DSP Virus/Pathogen Mini Kit (Qiagen). RNA isolation and library preparation is fully described in Butler, et al. [27 (link)].
+ Open protocol
+ Expand
4

Nasopharyngeal Swab SARS-CoV-2 Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patient specimens were processed as described in Butler et al. (2021) (link). Briefly, nasopharyngeal swabs were collected using the BD Universal Viral Transport Media system (Becton, Dickinson and Company, Franklin Lakes, NJ) from symptomatic patients. Total Nucleic Acid (TNA) was extracted from using automated nucleic acid extraction on the QIAsymphony and the DSP Virus/Pathogen Mini Kit (QIAGEN).
+ Open protocol
+ Expand
5

SARS-CoV-2 Nasopharyngeal Specimen Processing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patient specimens were processed as described in Butler et al. (2021) (link). Briefly, nasopharyngeal swabs were collected using the BD Universal Viral Transport Media system (Becton, Dickinson and Company, Franklin Lakes, NJ) from symptomatic patients. Total Nucleic Acid (TNA) was extracted from using automated nucleic acid extraction on the QIAsymphony and the DSP Virus/Pathogen Mini Kit (Qiagen).
+ Open protocol
+ Expand
6

SARS-CoV-2 RT-PCR from Nasopharyngeal Swabs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patient specimens were collected with patients’ consent at New York Presbyterian Hospital (NYPH) and then processed for RT-PCR as described previously30 (link). Nasopharyngeal (NP) swab specimens were collected using the BD Universal Viral Transport Media system (Becton, Dickinson and Company, Franklin Lakes, NJ) from symptomatic patients.
+ Open protocol
+ Expand
7

SARS-CoV-2 Diagnostic Workflow

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patient specimens were collected with patients’ consent at New York-Presbyterian Hospital-Weill Cornell Medical Center (NYPH-WCMC) and then processed for qRT-PCR. Nasopharyngeal (NP) swab specimens were collected using the BD Universal Viral Transport Media system (Becton, Dickinson and Company, Franklin Lakes, NJ) from symptomatic patients. Samples were collected and processed through the Weill Cornell Medicine Institutional Review Board (IRB) Protocol 19-11021069. All relevant ethical regulations for work with human participants were complied with. Observational cohort analysis (ACEI/ARB) was done through the Columbia University IRB Protocol AAAL0601. Oropharyngeal samples data from University Hospital of Tuebingen were collected under IRB 243/2020A.
+ Open protocol
+ Expand
8

RT-PCR Analysis of NP Swab Specimens

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patient specimens were collected with patients’ consent at New York Presbyterian Hospital and then processed for RT–PCR as described previously30 . NP swab specimens were collected using the BD Universal Viral Transport Media system (Becton, Dickinson and Company) from symptomatic patients.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!